• Adjusted Net Investment Income (NII): $44.7 million or $0.54 per share, down from $45.2 million or $0.55 per share in the prior quarter.
• Net Asset Value (NAV) per Share: Declined to $17.63 from $18.09 last quarter.
• Portfolio Fair Value: $2.8 billion invested across 136 companies as of December 31, 2024.
• Weighted Average Yield on Debt Investments: 10.7%.
• New Investment Commitments: $198 million with a weighted average yield of 9.6%.
• Paydowns, Exits, and Sales: Generated $352 million, up from $338 million in the fourth quarter.
• Investments on Nonaccrual Status: 3.9% of the portfolio at fair value and 5.1% at cost.
• Net Leverage Ratio: 1.03 times, down from 1.07 times last quarter.
• Total Debt Outstanding: $1.61 billion with a weighted average interest rate of 6.2%.
• Liquidity: Approximately $1.1 billion, including $113 million of cash and $958 million of undrawn capacity on credit facilities.
• Joint Ventures Investments: $470 million, primarily in broadly syndicated loans across 44 portfolio companies.
• Annualized ROE for Joint Ventures: Approximately 12% in aggregate.

• Warning! GuruFocus has detected 7 Warning Signs with OCSL.

Release Date: February 04, 2025

For the complete transcript of the earnings call, please refer to the full earnings call transcript.

Positive Points

• Oaktree Specialty Lending Corp (NASDAQ:OCSL) raised $100 million through the issuance of new common stock, enhancing its asset base and providing additional capital for investment opportunities.
• The company permanently amended its fee structure to include a total return hurdle, providing more clarity and potentially reducing fees for shareholders.
• OCSL introduced a new dividend policy with a base and supplemental dividend, aiming to provide stable returns to shareholders.
• The portfolio remains well-diversified with $2.8 billion in fair value across 136 companies, with a healthy weighted average yield of 10.7% on debt investments.
• OCSL's joint ventures generated an attractive annualized return on equity of approximately 12%, indicating strong performance in this segment.

Negative Points

• Net asset value per share declined from $18.09 to $17.63, reflecting a decrease in the company's overall valuation.
• The adjusted net investment income per share decreased slightly from $0.55 to $0.54, indicating a minor decline in profitability.
• Investments on nonaccrual status remained relatively unchanged at 3.9% of the portfolio at fair value, with new additions to the nonaccrual list, such as Dominion Diagnostics.
• The company faced challenges with certain underperforming assets, leading to further write-downs and impacting overall portfolio quality.
• The competitive environment led to a slight decline in the weighted average yield of new investment commitments, reflecting tighter spreads and increased competition.

Q & A Highlights

Q: Can you provide more details on the $100 million equity investment this quarter and future plans for it? A: Mathew Pendo, President, explained that the $100 million investment was made to provide significant dry powder and equity buying power to capitalize on deployment opportunities. The investment was made at the January 31 NAV, and the lockup provision is standard, preventing sales for a year. Oaktree has been a long-term shareholder and hasn't sold any stock to date.

Q: Why is there a strategic push towards more senior participations in larger companies? A: Armen Panossian, CEO and Co-Chief Investment Officer, stated that the focus on first lien lending is due to the attractive risk-adjusted returns in the current high-rate environment. The firm believes that first lien lending offers better value compared to junior debt, which requires higher returns that are often not justified by the risk.

Q: What are the options for the upcoming debt maturity this month? A: Mathew Pendo, President, mentioned that OCSL has plenty of liquidity and will consider all options, including using existing liquidity from credit facilities and potentially issuing in the unsecured market. The decision will be based on the market environment post-earnings.

Q: What are the short-term and medium-term goals for the company with the new dividend and management fee structure? A: Armen Panossian, CEO and Co-Chief Investment Officer, outlined goals to comfortably cover the dividend, grow the asset base, diversify the portfolio, and convert nonaccrual assets into performing credit assets. The changes aim to stabilize the dividend and improve NAV.

Q: How should we think about the supplemental dividend level going forward? A: Mathew Pendo, President, indicated that approximately 50% of the income above the base dividend will be paid out as a supplemental dividend.

Q: Will there be a cash drag due to the equity injection from Oaktree? A: Raghav Khanna, Co-Chief Investment Officer, noted that while it will take a couple of quarters to deploy the new equity, the strong pipeline should allow for fairly quick deployment, net of anticipated repayments.

Q: Why did Oaktree buy shares at NAV instead of at a market discount? A: Mathew Pendo, President, explained that buying at NAV allows for asset growth and diversification on the balance sheet, which is more beneficial than buying existing shares at a discount. Armen Panossian, CEO, added that this approach supports OCSL and its NAV, providing dry powder for attractive market opportunities.

Q: Does the new incentive fee structure include foreign currency gains and losses? A: Christopher McKown, CFO, confirmed that the incentive fee structure includes all capital gains and losses, including those from foreign currency movements, although the net impact is minimal due to hedging.

For the complete transcript of the earnings call, please refer to the full earnings call transcript.